News Headline Summary

NeoStem (NBS) receives notification of second year NIH grant award for first clinical study of VSEL technology in periodontitis

Reaction details (20:40)

- Co. shares moved 4.5% higher in reaction to the news from USD 9.21 to USD 9.63.

13 Sep 2013 - 20:39 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: